Scleroderma Clinical Trials Consortium Inc

Analysis

Scleroderma Clinical Trials Consortium Inc is a registered charity in United States, based in Boston, MA. It received its IRS tax-exemption ruling in June 2001, 25 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Scleroderma Clinical Trials Consortium Inc reported income of $264k and spending of $210k, leaving 21% of income unspent that year. Across the 5 years on record, from December 2019 to December 2023, income fell from $1.2m to $264k (-78%), an average of -32% a year. The sharpest change came in the year to December 2020, when income dropped by 82%. Over the whole period it spent 36% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Scleroderma Clinical Trials Consortium Inc sits at the 45th percentile: it is larger than about 45% of them. Against every charity in United States with reported income it ranks in the 59th percentile, and in the 62nd percentile within MA. Charities of a similar size with the same main cause include A Tree Planted Inc ($264k), Windhorse Guild Inc ($265k) and Society for Pain Practice Management ($264k).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 71% of the total. At year end it held assets of $3.5m against liabilities of $876k, net assets of $2.6m.